These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Transfusion of platelet concentrates]. Rieux C, Lee K, Lavaud A, Bierling P. Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645 [Abstract] [Full Text] [Related]
7. Prophylactic platelet transfusions. Cid J, Escolar G, Lozano M. N Engl J Med; 2010 Jun 03; 362(22):2140; author reply 2141-2. PubMed ID: 20519690 [No Abstract] [Full Text] [Related]
13. Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs. Julmy F, Ammann RA, Taleghani BM, Fontana S, Hirt A, Leibundgut K. Transfusion; 2009 Jan 03; 49(1):21-33. PubMed ID: 18774963 [Abstract] [Full Text] [Related]
14. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial. Snyder E, McCullough J, Slichter SJ, Strauss RG, Lopez-Plaza I, Lin JS, Corash L, Conlan MG, SPRINT Study Group. Transfusion; 2005 Dec 03; 45(12):1864-75. PubMed ID: 16371039 [Abstract] [Full Text] [Related]
15. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G, Barbui T, Mandelli F, Sirchia G. N Engl J Med; 1997 Dec 25; 337(26):1870-5. PubMed ID: 9407153 [Abstract] [Full Text] [Related]
16. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients. Slichter SJ. J Clin Apher; 2006 Apr 25; 21(1):78-84. PubMed ID: 16619231 [Abstract] [Full Text] [Related]